Estrogen Replacement Therapy Global Market Report 2025
상품코드:1810893
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
에스트로겐 대체 요법 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 119억 7,000만 달러로 성장하며, CAGR은 4.8%에 달합니다. 예측 기간 중 예상되는 성장은 사회적 인식의 변화, 조기 폐경 증가, 피임약 사용 증가, 환자의 건강 문해력 향상, 난소 기능 부전 진단 빈도 증가 등과 관련이 있습니다. 이 기간 중 예상되는 주요 동향으로는 약물전달 시스템의 혁신, 개인 맞춤형 호르몬 치료의 부상, 생동일성 호르몬 개발의 발전, 디지털 헬스 기술의 통합, 식물 유래 에스트로겐 대체품의 발전 등을 들 수 있습니다.
원격의료의 도입 확대는 향후 수년간 에스트로겐 대체요법 시장의 성장을 촉진할 것으로 예측됩니다. 원격의료는 디지털 통신 기술을 통해 원격지에서 헬스케어 서비스를 제공하는 것으로, 환자가 그 자리에 있지 않아도 진료나 치료를 받을 수 있습니다. 이 접근 방식은 특히 외딴 지역이나 서비스가 부족한 지역에 거주하는 사람들에게 의료 전문가와의 연결을 용이하게 함으로써 의료 서비스 접근성을 향상시킵니다. 원격의료는 특히 부인과 의료가 제한적인 지역에서 여성들이 자주 방문하지 않고도 전문의의 진찰과 호르몬 치료 처방을 받을 수 있게 함으로써 에스트로겐 대체요법에 대한 수요를 지원하고 있습니다. 예를 들어 미국에 본사를 둔 디지털 헬스 투자 회사인 록헬스(Rock Health)는 2023년 2월 8,014명의 참가자를 대상으로 한 설문조사에서 80%가 2022년 7월 12일부터 8월 22일 사이에 적어도 한 번 이상 원격의료를 이용한 경험이 있으며, 이는 2021년 72%에서 증가한 수치라고 보고했습니다. 이러한 추세는 원격의료의 이용 증가가 에스트로겐 대체요법 시장의 성장에 기여하고 있음을 보여줍니다.
에스트로겐 대체요법 시장의 주요 기업은 생동일성 에스트라디올과 같은 개별 호르몬 수준과 용량에 대한 요구를 더 잘 충족시킬 수 있는 첨단 치료법을 개발하고 있습니다. 생동일성컬 에스트라디올은 인체에서 자연적으로 생성되는 에스트로겐과 동일한 분자 구성을 가진 에스트로겐을 실험실에서 만든 것으로, 호르몬 요법에서 일반적으로 사용됩니다. 2024년 5월, 인도 제약사 Jagson Pearl Pharmaceuticals Limited는 생동일성 에스트라디올과 생동일성 프로게스테론을 모두 함유한 1일 1회 경구용 호르몬 대체요법제 멤업(Memup)을 출시했습니다. 두 성분 모두 미국 식품의약국(FDA)의 승인을 받았습니다. 멤업은 안면홍조, 식은땀, 수면장애 등 갱년기 관련 증상을 관리하는 것을 목표로 하는 여성 건강의 중요한 진전입니다. 이 치료법은 현대적이고 효과적인 호르몬 치료에 대한 수요 증가에 대응하기 위한 것입니다. 체내 천연 호르몬을 모방한 제형과 1캡슐의 편리함으로 복약 순응도 강화과 치료 성적 개선을 촉진합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 에스트로겐 대체 요법 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 에스트로겐 대체 요법 시장 : 성장률 분석
세계의 에스트로겐 대체 요법 시장 실적 : 규모와 성장, 2019-2024
세계의 에스트로겐 대체 요법 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 에스트로겐 대체 요법 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 에스트로겐 대체 요법 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
토픽
경피
질
비경구
세계의 에스트로겐 대체 요법 시장제형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
패치
겔
임플란트
주사
좌약
세계의 에스트로겐 대체 요법 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 에스트로겐 대체 요법 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
폐경
성선기능저하증
골다공증
기타 용도
세계의 에스트로겐 대체 요법 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
홈케어
기타 최종사용자
세계의 에스트로겐 대체 요법 시장 : 서브 세분화, 경구, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
결합형 에스트로겐정
에스트라디올정
에스트로피페이트정
에스트로겐-프로게스틴 배합정
세계의 에스트로겐 대체 요법 시장 : 서브 세분화, 토픽별, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
에스트로겐 크림
에스트로겐 젤
에스트로겐스프레이
에스트로겐 유제
세계의 에스트로겐 대체 요법 시장 : 서브 세분화, 경피 흡수형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
경피패치
경피겔
마이크로니들 패치
세계의 에스트로겐 대체 요법 시장 : 서브 세분화, 질, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
질 크림
질정 또는 삽입물
질링
질좌약
세계의 에스트로겐 대체 요법 시장 : 서브 세분화, 비경구제, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
근육내 주사
피하 임플란트
정맥내 제제
제7장 지역별·국가별 분석
세계의 에스트로겐 대체 요법 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 에스트로겐 대체 요법 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
에스트로겐 대체 요법 시장 : 경쟁 구도
에스트로겐 대체 요법 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Novartis AG
Novo Nordisk A/S
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Perrigo Company Plc
Gedeon Richter Plc
Orion Corporation
Hisamitsu Pharmaceutical Co. Inc.
ANI Pharmaceuticals Inc.
Theramex Limited
Noven Pharmaceuticals Inc.
Besins Healthcare S.A.
TherapeuticsMD Inc.
Montage Labs Inc.
Gynogen GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
에스트로겐 대체 요법 시장 2029 : 새로운 기회를 제공하는 국가
에스트로겐 대체 요법 시장 2029 : 새로운 기회를 제공하는 부문
에스트로겐 대체 요법 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Estrogen replacement therapy is a medical treatment designed to supplement the body with estrogen hormones in order to maintain or restore hormonal balance. Administered under clinical guidance, it targets the physiological changes resulting from decreased estrogen levels. The treatment involves the use of synthetic or bioidentical estrogen to support the regulation of internal hormonal activity.
The primary forms of estrogen replacement therapy include oral, topical, transdermal, vaginal, and parenteral options. Oral therapies consist of pills or capsules taken by mouth and absorbed through the digestive tract. The therapy is available in multiple dosage forms, including tablets, patches, gels, implants, injections, and suppositories, and is distributed via hospital pharmacies, retail pharmacies, online pharmacies, and other channels. It is used to treat conditions such as menopause, hypogonadism, and osteoporosis, among others, and is utilized across various settings, including hospitals, clinics, home care, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The estrogen replacement therapy market research report is one of a series of new reports from The Business Research Company that provides estrogen replacement therapy market statistics, including estrogen replacement therapy industry global market size, regional shares, competitors with a estrogen replacement therapy market share, detailed estrogen replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the estrogen replacement therapy industry. This estrogen replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The estrogen replacement therapy market size has grown strongly in recent years. It will grow from $9.45 billion in 2024 to $9.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth during the historical period can be attributed to an aging female demographic, increased life expectancy, urbanization and evolving lifestyle patterns, greater awareness of menopause management, and the expansion of the female workforce.
The estrogen replacement therapy market size is expected to see steady growth in the next few years. It will grow to $11.97 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The projected growth in the forecast period can be linked to shifting societal perceptions, a rising occurrence of early menopause, increased use of contraceptives, greater patient health literacy, and more frequent diagnoses of ovarian dysfunction. Key trends expected during this time include innovations in drug delivery systems, the rise of personalized hormone therapies, advancements in bioidentical hormone development, integration of digital health technologies, and progress in plant-based estrogen alternatives.
The growing adoption of telemedicine is expected to drive the expansion of the estrogen replacement therapy market in the coming years. Telemedicine involves the delivery of healthcare services remotely through digital communication technologies, enabling patients to access medical consultations and treatments without being physically present. This approach improves healthcare accessibility, particularly for individuals in remote or underserved locations, by allowing easier connections with medical professionals. The increased use of telemedicine supports the demand for estrogen replacement therapy, as it allows women to receive expert consultations and prescriptions for hormone treatments without the need for frequent in-person visits, especially in areas with limited gynecological care. For example, in February 2023, Rock Health, a U.S.-based digital health investment firm, reported that a survey of 8,014 participants found 80% had used telemedicine at least once between July 12 and August 22, 2022, an increase from 72% in 2021. This trend indicates that the rising use of telemedicine is contributing to the growth of the estrogen replacement therapy market.
Leading companies in the estrogen replacement therapy market are developing advanced therapies, such as bioidentical estradiol, to better meet individual hormone levels and dosage needs. Bioidentical estradiol is a laboratory-created form of estrogen that has the same molecular composition as the estrogen naturally produced by the human body and is commonly used in hormone therapy. In May 2024, Jagsonpal Pharmaceuticals Limited, an India-based pharmaceutical firm, launched MemUp, a hormone replacement therapy product that delivers a once-daily oral dose containing both bioidentical estradiol and bioidentical progesterone. Both components are approved by the U.S. Food and Drug Administration. MemUp represents a significant advancement in women's health, aiming to manage menopause-related symptoms such as hot flashes, night sweats, and sleep disturbances. The therapy addresses increasing demand for modern, effective hormone treatments. With its formulation mimicking the body's natural hormones and its single-capsule convenience, it promotes better adherence and improved treatment outcomes.
In September 2023, LifeMD Inc., a telehealth company based in the U.S., partnered with Ascend Therapeutics to introduce a direct-to-consumer hormone therapy program. This collaboration allows patients to access licensed healthcare providers through LifeMD's telehealth platform, which can be reached via the EstroGel website. Following prescription approval, the medication is delivered directly to the patient's home, offering added convenience. Ascend Therapeutics is a U.S.-based company specializing in estrogen replacement therapy.
Major players in the estrogen replacement therapy market are Pfizer Inc., Merck & Co. Inc., Bayer AG, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc, Gedeon Richter Plc, Orion Corporation, Hisamitsu Pharmaceutical Co. Inc., ANI Pharmaceuticals Inc., Theramex Limited, Noven Pharmaceuticals Inc., Besins Healthcare S.A., TherapeuticsMD Inc., Montage Labs Inc., and Gynogen GmbH.
North America was the largest region in the estrogen replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in estrogen replacement therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the estrogen replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The estrogen replacement therapy market consists of revenues earned by entities by providing services such as hormone level testing, monitoring and follow-up services, virtual care, and wellness coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The estrogen replacement therapy market also includes sales of estrogen pellets, bioidentical estrogen compounds, estrogen-loaded transdermal films, and dual-action hormone devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Estrogen Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on estrogen replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for estrogen replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The estrogen replacement therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Oral; Topical; Transdermal; Vaginal; Parenteral
2) By Dosage Form: Tablets; Patches; Gels; Implants; Injections; Suppositories
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
4) By Application: Menopause; Hypogonadism; Osteoporosis; Other Applications
5) By End-User: Hospitals; Clinics; Homecare; Other End-Users
3. Estrogen Replacement Therapy Market Trends And Strategies
4. Estrogen Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Estrogen Replacement Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Estrogen Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Estrogen Replacement Therapy Market Growth Rate Analysis
5.4. Global Estrogen Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Estrogen Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Estrogen Replacement Therapy Total Addressable Market (TAM)
6.1. Global Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Transdermal
Vaginal
Parenteral
6.2. Global Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Patches
Gels
Implants
Injections
Suppositories
6.3. Global Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.4. Global Estrogen Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Menopause
Hypogonadism
Osteoporosis
Other Applications
6.5. Global Estrogen Replacement Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare
Other End-Users
6.6. Global Estrogen Replacement Therapy Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conjugated Estrogens Tablets
Estradiol Tablets
Estropipate Tablets
Combined Estrogen-Progestin Tablets
6.7. Global Estrogen Replacement Therapy Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Creams
Estrogen Gels
Estrogen Sprays
Estrogen Emulsions
6.8. Global Estrogen Replacement Therapy Market, Sub-Segmentation Of Transdermal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transdermal Patches
Transdermal Gels
Microneedle Patches
6.9. Global Estrogen Replacement Therapy Market, Sub-Segmentation Of Vaginal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vaginal Creams
Vaginal Tablets Or Inserts
Vaginal Rings
Vaginal Suppositories
6.10. Global Estrogen Replacement Therapy Market, Sub-Segmentation Of Parenteral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intramuscular Injections
Subcutaneous Implants
Intravenous Formulations
7. Estrogen Replacement Therapy Market Regional And Country Analysis
7.1. Global Estrogen Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Estrogen Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Estrogen Replacement Therapy Market
9.1. China Estrogen Replacement Therapy Market Overview
9.2. China Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Estrogen Replacement Therapy Market
10.1. India Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Estrogen Replacement Therapy Market
11.1. Japan Estrogen Replacement Therapy Market Overview
11.2. Japan Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Estrogen Replacement Therapy Market
12.1. Australia Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Estrogen Replacement Therapy Market
13.1. Indonesia Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Estrogen Replacement Therapy Market
14.1. South Korea Estrogen Replacement Therapy Market Overview
14.2. South Korea Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Estrogen Replacement Therapy Market
15.1. Western Europe Estrogen Replacement Therapy Market Overview
15.2. Western Europe Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Estrogen Replacement Therapy Market
16.1. UK Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Estrogen Replacement Therapy Market
17.1. Germany Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Estrogen Replacement Therapy Market
18.1. France Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Estrogen Replacement Therapy Market
19.1. Italy Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Estrogen Replacement Therapy Market
20.1. Spain Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Estrogen Replacement Therapy Market
21.1. Eastern Europe Estrogen Replacement Therapy Market Overview
21.2. Eastern Europe Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Estrogen Replacement Therapy Market
22.1. Russia Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Estrogen Replacement Therapy Market
23.1. North America Estrogen Replacement Therapy Market Overview
23.2. North America Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Estrogen Replacement Therapy Market
24.1. USA Estrogen Replacement Therapy Market Overview
24.2. USA Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Estrogen Replacement Therapy Market
26.1. South America Estrogen Replacement Therapy Market Overview
26.2. South America Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Estrogen Replacement Therapy Market
27.1. Brazil Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Estrogen Replacement Therapy Market
28.1. Middle East Estrogen Replacement Therapy Market Overview
28.2. Middle East Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Estrogen Replacement Therapy Market
29.1. Africa Estrogen Replacement Therapy Market Overview
29.2. Africa Estrogen Replacement Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Estrogen Replacement Therapy Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Estrogen Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Estrogen Replacement Therapy Market Competitive Landscape And Company Profiles
